ノースカロライナにおける片頭痛の臨床試験
ノースカロライナ内の拠点で、片頭痛に関する12件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
Study of EVO756 in Adults With Migraine
- Asheville Neurology Specialists, Pa, Asheville
- Eximia Research NC, Raleigh
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/10/02更新 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Accellacare - Piedmont, Statesville
- Accellacare of Piedmont HealthCare, Statesville
- Accellacare US Inc., Winston-Salem
被験者募集中第1相
6歳〜11歳 · 全性別 · 2026/09/28更新 · NCT06995729Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- OnSite Clinical Solutions, LLC, Charlotte
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- OnSite Clinical Solutions, LLC, Charlotte
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT04649242Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Onsite Clinical Solutions Park Cedar Dr., Charlotte
- Onsite Clinical Solutions Mecklenburg, Charlotte
- Onsite Clinical Solutions Ballantyne, Charlotte
- 他2件
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/16更新 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Onsite Clinical Solutions - Don Lochman Lane - Charlotte /ID# 282834, Charlotte
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/14更新 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Queen City Clinical Research, PLLC, Charlotte
被験者募集中
22歳〜84歳 · 全性別 · 2026/08/28更新 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- OnSite Clinical Solutions, Charlotte
- Guildford Neurologic Research Partners, LLC, Greensboro
- Headache Wellness Center, Greensboro
- 他2件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/20更新 · NCT07645924BE WELL With Migraine: Brain Education and WELLness With Migraine
- Wake Forest University Health Sciences, Winston-Salem
被験者募集中
18歳以上 · 全性別 · 2026/06/12更新 · NCT05987592Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- Evidera, a PPD business unit, Wilmington
被験者募集中観察研究
0歳以上 · 女性 · 2026/05/05更新 · NCT05046613Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
- Iqvia /Id# 266904, Durham
被験者募集中観察研究
18歳以上 · 女性 · 2025/12/15更新 · NCT05158894Aimovig Pregnancy Exposure Registry
- IQVIA Virtual Site, Durham
被験者募集中観察研究健康なボランティア歓迎
18歳〜99歳 · 女性 · 2025/11/04更新 · NCT06150781ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。